表纸
市场调查报告书

心脏标记分析仪的全球市场:产品分析,公司业务/营销策略,主要交易

Global Cardiac Marker Analyzer Market, Product Analysis, Companies Business & Marketing Strategy, Major Deals

出版商 iGate Research Pvt Ltd 商品编码 949233
出版日期 内容资讯 英文 118 Pages
订单完成后即时交付
价格
心脏标记分析仪的全球市场:产品分析,公司业务/营销策略,主要交易 Global Cardiac Marker Analyzer Market, Product Analysis, Companies Business & Marketing Strategy, Major Deals
出版日期: 2020年07月14日内容资讯: 英文 118 Pages
简介

到2026年,全球心脏标记分析仪市场预计将达到45亿美元。作为一种诊断范例,心脏标记分析仪可以在几分钟内提供敏感而可靠的信息,使其既适合即时检验也适合实验室使用。诸如心血管疾病的发病率增加,人口激增的老龄化,公共和私人组织对心脏生物标志物研究的资金增加以及正在进行的临床试验以识别市场上新的心脏生物标志物等因素。它正在推动增长。但是,诸如与样本收集和存储有关的技术问题以及与监管和赎回系统有关的问题等因素是阻碍市场增长的一些主要障碍。

该报告调查了全球心脏标记分析仪市场,并提供了有关市场趋势和预测,COVID-19的影响,竞争格局以及主要公司的产品/趋势/策略分析的信息。

内容

第1章执行摘要

第2章COVID-19的影响

第三章市场与预测(2011-2026)

第4章心脏标记公司:比较测试分析

第5章竞争对手分析

第6章Alere(现为Abbott)

  • Alere分诊
    • Alere Cardiology 净销售额(2010-2016)

第7章Quidel Corporation

  • Quidel Triage system
    • Quidel Cardiac Immunoassay 净销售额(2017-2026)

第8章Abbott Point of Care

  • i-STAT系统
  • Abbott Laboratories Point of Care Diagnostics 净销售额(2011-2026)

第9章Roche

  • Cobas h 232 POC System

第10章 Beckman Coulter

  • Access 2 Immunoassay System

第11章Siemens Healthineers

  • Stratus CS Analyzer
  • Siemens Healthineers:建立全球数位生态系统,促进医疗保健的数位化

第12章Response Biomedical

  • 心血管检查
    • 急性心肌梗塞(心脏病)测试
    • 充血性心力衰竭(CHF)测试
    • 血栓形成试验
  • RAMP平台
    • RAMP 200
    • RAMP Reader
  • 响应心血管测试
    • RAMP;肌钙蛋白I
    • RAMP; NT-proBNP
    • RAMP;肌红蛋白
    • RAMP; CK-MB
    • RAMP; D-DIMER
    • 响应心血管测试的净销售额(2010-2026)

第13章Boditech

  • i-chroma DUO Analyzer

第14章Lifesign

  • DXpress Reader Analyzer

第15章LSI Medience Corporation

  • PATHFAST Analyzer

第16章CardioGenics Holdings Inc.

  • QL Care Analyzer

第17章Trinity Biotech

  • Meritas POC Analyzer
  • Trinity Biotech Point of Care Diagnostics净销售额(2010-2019)

第18章合并,收购和许可协议

  • Alere Inc
  • CardioGenics
  • Response Biomedical
  • Abbott Laboratories
  • Siemens Healthineers
  • LSI Medience Corporation
  • Trinity Biotech
  • Quidel

第19章新标记

第20章Response Biomedical:商业和营销策略

  • 在中国的新代理商
  • 与日本Alere Medical结成战略联盟
  • Response Biomedical:加拿大卫生部批准和CE标志
  • 专注于提高效率和降低成本

第21章Roche:业务和营销策略

  • 完全连接的核心实验室实施
  • 罗氏(Roche):宣布提高准确性的即时护理(POC)肌钙蛋白测试
  • 罗氏(Roche):宣布平板电脑的新移动应用程序

第22章Boditech Med Inc:业务和营销策略

  • Boditech Med收购免疫学
  • 多元化的营销渠道

第23章 Siemens Healthineers:业务和营销策略

  • Siemens Healthineers:Teamplay Digital Health Platform发布
  • Siemens Healthineers:宣布新的战略关系
  • Siemens与Imricor之间的战略联盟
  • Siemens Healthineers:提供高度敏感的肌钙蛋白I IVD分析
  • Siemens Healthineers:建立促进医疗保健数位化的全球数位生态系统
  • Siemens Healthineers和Ebit联盟
目录

The global Cardiac Marker Analyzer market is predicted to reach US$ 4.5 Billion by 2026. Cardiac biomarkers are used as risk stratification for various cardiovascular diseases (CVDs), which include myocardial infraction, congestive heart failure, acute coronary syndrome (ACS) among others. The cardiac biomarkers that are widely used as an integrated diagnostic approach for CVDs include CK-MB, troponin I and T, myoglobin, BNPs, IMA and few others. The prevention of cardiac diseases by monitoring the heart conditions via cardiac biomarker testing is the profound approach for obtaining rapid results for immediate diagnosing and treatment.

Cardiac Marker analyzer represents a paradigm in diagnostics that provides high sensitivity and reliable information in minutes. It is ideally suited to both point of care testing and laboratory use. The factors such as increasing incidences of cardiovascular diseases, rapidly increasing geriatric population, growing funding from public-private organizations for research on cardiac biomarkers, and ongoing clinical trials for the identification of novel cardiac biomarkers are driving the growth of the market. However, factors such as technical problems related to sample collection and storage and issues related to regulatory and reimbursement systems are some of the key factors hampering the growth of this market.

Key Highlights of the Report

  • In October 2017, Abbott completed its acquisition of Alere, concluding a deal first announced in February 2016.
  • Abbott Point of Care Diagnostics sales is driven by continued adoption of Abbott's i-STAT handheld system.
  • Quidel's cardiac immunoassay revenue was valued around US$ 266.5 Million in 2019.
  • Cobas H232 POC system permits rapid and easy determination of cardiac blood markers such as Troponin T, NT-proBNP, D-dimer, CK-MB and myoglobin.
  • A major focus of Response Biomedical development programs in cardiovascular testing has been clinical tests for the quantification of cardiovascular markers.
  • Response Biomedical sells tests that detect three of the primary markers for the detection of an acute myocardial infarction: Troponin I, Myoglobin and CK-MB.
  • In March 2020, Siemens Healthineers announced market introduction of the teamplay digital health platform.
  • CardioGenics is the only company to successfully deploy CL in a compact, fully automated POC platform.
  • Abbott acquired St. Jude Medical, to reap benefits of the latter's strong global position in thriving cardiac areas such as heart failure, atrial fibrillation, structural heart, and chronic pain complement.
  • Trinity Biotech Point-of-Care revenues declined in 2019 by around 23.2% from the previous year figure.
  • In October 2017, Boditech Med has made an agreement with their Chinese distributor, Joinstar, to supply their products for US$ 48 Million over three years.

iGATE RESEARCH report titled "Global Cardiac Marker Analyzer Market, Product Analysis, Companies Business & Marketing Strategy, Major Deals" provides a comprehensive assessment of the cardiac marker analyzer segments, comparative tests analysis, competitive product analysis, product features & benefits, merger & acquisitions, strategic alliances and Companies Business and Market Strategies.

This 118 Page report with 10 Figures and 19 Tables has been studied from 7 View Points:

  • 1. Cardiac Marker Analyzer Market & Forecast (2011 - 2026)
  • 2. Cardiac Marker Companies - Comparative Tests Analysis
  • 3. Cardiac Marker Analyzer - Competitive Product Analysis
  • 4. Cardiac Marker Analyzer - Specifications, Product Features & Benefits Analysis
  • 5. Cardiac Marker Analyzer - Mergers, Acquisitions, Distribution, Partnership and Licensing Agreements
  • 6. Emerging Markers Analysis
  • 7. Companies Business & Marketing Strategy

The Cardiac Marker Analyzer Covered in the report are as follows:

  • 1. Triage MeterPro Analyzer
  • 2. The i-STAT System
  • 3. Cobas h 232 POC System
  • 4. Access 2 Immunoassay System
  • 5. Stratus CS Analyzer
  • 6. RAMP 200
  • 7. RAMP Reader
  • 8. i-chroma DUO Analyzer
  • 9. Dxpress Reader Analyzer
  • 10. PATHFAST Analyzer
  • 11. QL Care Analyzer
  • 12. Meritas POC Analyzer

Cardiac Marker Analyzer - Key Company Analysis

  • 1. Alere (Now Abbott)
  • 2. Abbott Point of Care
  • 3. Quidel Corporation
  • 4. Roche
  • 5. Beckman Coulter
  • 6. Siemens Healthineers
  • 7. Response Biomedical
  • 8. Boditech
  • 9. Lifesign
  • 10. LSI Medience Corporation
  • 11. CardioGenics Holdings Inc.
  • 12. Trinity Biotech

Data Sources

iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

  • Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.
  • Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

Table of Contents

1. Executive Summary

2. Impact of COVID-19 on Global Cardiac Marker Analyzer Market

3. Global Cardiac Marker Analyzer Market & Forecast (2011-2026)

4. Cardiac Marker Companies-Comparative Tests Analysis

5. Cardiac Marker Analyzer-Competitive Product Analysis

6. Alere (Now Abbott)

  • 6.1. Alere Triage
    • 6.1.1. Alere Cardiology Net Sales (2010-2016)

7. Quidel Corporation

  • 7.1. Quidel Triage system
    • 7.1.1. Quidel Cardiac Immunoassay Net Sales (2017-2026)

8. Abbott Point of Care

  • 8.1. The i-STAT System
  • 8.2. Abbott Laboratories Point of Care Diagnostics Sales (2011-2026)

9. Roche

  • 9.1. Cobas h 232 POC System

10. Beckman Coulter

  • 10.1. Access 2 Immunoassay System

11. Siemens Healthineers

  • 11.1. Stratus CS Analyzer
  • 11.2. Siemens Healthineers establishes global Digital Ecosystem to drive Digitalization of Healthcare

12. Response Biomedical

  • 12.1. Cardiovascular Testing
    • 12.1.1. Acute Myocardial Infarction (Heart Attack) Testing
    • 12.1.2. Congestive Heart Failure ("CHF") Testing
    • 12.1.3. Thrombotic Disease Testing
  • 12.2. RAMP Platform
    • 12.2.1. RAMP 200
    • 12.2.2. RAMP Reader
  • 12.3. Response Cardiovascular Testing
    • 12.3.1. RAMP® TROPONIN I
    • 12.3.2. RAMP® NT-proBNP
    • 12.3.3. RAMP® MYOGLOBIN
    • 12.3.4. RAMP® CK-MB
    • 12.3.5. RAMP® D-DIMER
    • 12.3.6. Response Biomedical Cardiovascular Net Sales (2010-2026)

13. Boditech

  • 13.1. i-chroma DUO Analyzer

14. Lifesign

  • 14.1. DXpress Reader Analyzer

15. LSI Medience Corporation

  • 15.1. PATHFAST Analyzer

16. CardioGenics Holdings Inc.

  • 16.1. QL Care Analyzer

17. Trinity Biotech

  • 17.1. Meritas POC Analyzer
  • 17.2. Trinity Biotech Point of Care Diagnostics Sales (2010-2019)

18. Mergers, Acquisitions and Licensing Agreements

  • 18.1. Alere Inc
  • 18.2. CardioGenics
  • 18.3. Response Biomedical
  • 18.4. Abbott Laboratories
  • 18.5. Siemens Healthineers
  • 18.6. LSI Medience Corporation
  • 18.7. Trinity Biotech
  • 18.8. Quidel

19. Emerging Markers

20. Response Biomedical-Business & Marketing Strategy

  • 20.1. New Distributors in China
  • 20.2. Strategic Alliances with Alere Medical in Japan
  • 20.3. Response Biomedical Receives Health Canada Approval and CE Mark
  • 20.4. Focus on Improving Efficiencies and Reducing Costs

21. Roche-Business & Marketing Strategy

  • 21.1. Implementing the Fully Connected Core Laboratory
  • 21.2. Roche Launches Point-Of-Care (POC) Troponin Test with Improved Accuracy
  • 21.3. Roche Launches New Mobile Application for Tablets

22. Boditech Med Inc-Business and Marketing Strategy

  • 22.1. Boditech Med Acquires Immunostics
  • 22.2. Diversifying Marketing Channel

23. Siemens Healthineers-Business and Marketing Strategy

  • 23.1. Siemens Healthineers Introduces Teamplay Digital Health Platform
  • 23.2. Siemens Healthineers Announces New Strategic Relationship
  • 23.3. Strategic Partnership between Siemens and Imricor
  • 23.4. Siemens Healthineers Offers True High-Sensitivity Troponin I IVD Assay
  • 23.5. Siemens Healthineers Establishes Global Digital Ecosystem to Drive Digitalization of Healthcare
  • 23.6. Partnership between Siemens Healthineers and Ebit

List of Figures:

  • Figure 3-1: Global - Cardiac Marker Analyzer Market (Million US$), 2011 - 2019
  • Figure 3-2: Global - Forecast for Cardiac Marker Analyzer Market (Million US$), 2020 - 2026
  • Figure 6-1: Global - Alere Cardiology Net Sales (Million US$), 2010 - 2016
  • Figure 7-1: Quidel - Cardiac Immunoassay Revenue (Million US$), 2017 - 2019
  • Figure 7-2: Quidel - Forecast for Cardiac Immunoassay Revenue (Million US$), 2020 - 2026
  • Figure 8-1: Global - Abbott Laboratories Point of Care Diagnostics Sales (Million US$), 2011 - 2019
  • Figure 8-2: Global - Forecast for Abbott Laboratories Point of Care Diagnostics Sales (Million US$), 2020 - 2026
  • Figure 12-1: Global - Response Biomedical Cardiovascular Product Sales (Million US$), 2010 - 2019
  • Figure 12-2: Global - Forecast for Response Biomedical Cardiovascular Product Sales (Million US$), 2020 - 2026
  • Figure 17-1: Global - Trinity Biotech Point of Care Diagnostics Sales (Million US$), 2010 - 2019

List of Tables:

  • Table 4-1: Cardiac Marker Companies - Comparative Tests Analysis
  • Table 4-2: Cardiac Marker Companies - Comparative Tests Analysis
  • Table 4-3: Cardiac Marker Companies - Comparative Tests Analysis
  • Table 5-1: Cardiac Marker Analyzer - Competitive Product Analysis
  • Table 5-2: Cardiac Marker Analyzer - Competitive Product Analysis
  • Table 6-1: Alere - Triage Product Analytes
  • Table 15-1: PATHFAST - Technical Specifications
  • Table 18-1: Alere - Merger & Acquisition, 2007 - 2017
  • Table 18-2: Alere - Distribution/Partnership Agreement, 2008, 2016
  • Table 18-3: CardioGenics - Mergers & Acquisition, 2015
  • Table 18-4: CardioGenics - Licensing Agreement, 2012
  • Table 18-5: Response Biomedical - Distribution Agreement, 2011 - 2015
  • Table 18-6: Response Biomedical - Collaboration Deal, 2004 - 2015
  • Table 18-7: Abbott Laboratories - Merger & Acquisition, 2003, 2017, 2019
  • Table 18-8: Siemens Healthineers - Merger & Acquisition, 2017
  • Table 18-9: Siemens Healthineers - Strategic Partnership, 2017
  • Table 18-10: LSI Medience Corporation - Strategic Alliance, 2014
  • Table 18-11: Trinity Biotech - Merger & Acquisition, 2012
  • Table 18-12: Quidel Corporation - Merger & Acquisition, 2017